NEW

Philips Showcases Tele-Ultrasound at AIUM Virtual Event

Royal Philips announced its participation in the upcoming Annual Integrative Ultrasound Meeting (AIUM) virtual event, April 11-14, hosted by the American Institute of Ultrasound in Medicine.

FUJIFILM Healthcare starts to operate as Fujifilm Group company

Adding CT/MRI and other medical devices to the lineup to globally provide value-added solutions based on medical IT

Hyperfine Launches ‘Total Rethink Buying Process’

Hyperfine Research announced in a press release that it is pioneering a wholesale simplification of the capital equipment purchasing experience with the launch of its Total Rethink Buying Process.

Cardinal Health Launches Navista TS

Cardinal Health Specialty Solutions has launched Cardinal Health Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve outcomes and costs associated with patient treatment as they transition to value-based care.

MITA Applauds CMS for Creation of Medicare Coverage Pathway for Innovative Medical Technologies

The Medical Imaging & Technology Alliance (MITA)The Medical Imaging & Technology Alliance (MITA), the leading organization and collective voice of medical imaging equipment, radiopharmaceutical, contrast media, and focused ultrasound device manufacturers, today applauded the Centers for Medicare & Medicaid Services (CMS) for its recently issued final rule concerning the Medicare Coverage of Innovative Technology (MCIT) program. As finalized, the rule will reduce the lag between Food and Drug Administration (FDA) marketing authorization and subsequent Medicare coverage for innovative medical devices.

“The MCIT final rule is a major regulatory win – not only for MITA, which has actively advocated for swifter market access policies, but also for countless American patients who will now have expanded access to innovative, FDA-authorized medical solutions that would otherwise be left in limbo,” said Patrick Hope, Executive Director of MITA.

Specifically, the final rule creates a Medicare coverage pathway that expedites patient access to innovative medical devices with FDA “breakthrough” designation. As finalized, the rulemaking grants a drug or device designated by the FDA as “breakthrough” with immediate, four-year Medicare coverage.

Before the rule’s finalization, MITA submitted comments supporting the Agency’s proposed changes to the MCIT program, which were announced in September of 2020. Along with a formal comment letter, MITA joined the Focused Ultrasound (FUS) Foundation to publicly urge the Agency to create the new Medicare coverage pathway.

“As CMS works to implement this important policy update in the final days of the current Administration, we strongly urge President-elect Biden and his health team to uphold this change and continue on the path towards greater patient access to these innovative medical solutions,” Hope concluded.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *